Skip to main content
. 2023 Dec 2;16:357. doi: 10.1186/s13104-023-06625-3

Table 2.

Base line clinical characteristics of patients

Variables Categories Survival status Total (%)
Censored (%) Event (%)
Functional status Working 188 (68.36) 87 (31.64) 275 (68.2)
Ambulatory 23 (22.77) 78 (77.2) 101 (25.1)
Bedridden 14 (51.85) 13 (48.15) 27 (6.7)
Adherence Poor 7 (43.75) 9 (56.25) 16 (4.0)
Fair 43 (49.43) 44 (50.57) 87 (21.6)
Good 175 (58.33) 125 (41.67) 300 (74.4)
WHO clinical stage Stage-I 114 (50.89) 110 (49.11) 224 (55.6)
Stage-II 53 (68.83) 24 (31.17) 77 (19.1)
Stage-III 47 (63.51) 27 (36.49) 74 (18.4)
Stage-IV 11 (39.29) 17 (60.71) 28 (6.9)
TB screen No 216 (62.25) 131 (37.75) 347 (86.1)
Yes 9 (16.07) 47 (83.93) 56 (13.9)
OIs No 198 (61.68) 123 (38.32) 321 (79.7)
Yes 27 (32.93) 55 (67.07) 82 (20.3)
OCC No 203 (64.65) 111 (35.35) 314 (77.9)
Yes 22 (24.72) 67 (75.28) 89 (22.1)
Continuous variables Minimum Maximum Mean Standard error
Hematocrit in % 20.80 54.30 37.66 4.50
White blood cell in 103/μl 1.60 13.00 6.01 1.88
Red Blood Cell in 106/μl 2.00 11.00 4.17 1.35
Platelet in 103/μl 23 641 286.93 95.25
Lymphocyte in % 15.20 69.10 42.69 11.32
Monocyte in % 2.0 13.4 7.33 3.13